Bernard Haffey, President and CEO of NDO Surgical, Inc. will talk about the company’s first product, the Plicator®, which treats gastroesophageal reflux disease (GERD), a debilitating condition that affects 15 million Americans.
WilmerHale is a sponsor of this event, presented by the MIT Enterprise Forum of Cambridge.
Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.
Thank you for your interest in WilmerHale.
